Molecular targets in arthritis and recent trends in nanotherapy
Kislay Roy, Rupinder Kaur Kanwar, Jagat Rakesh Kanwar Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), Centre for Molecular and Medical Research (C-MMR), Strategic Research Centre, School of Medicine (SoM), Faculty of Health, Deakin University, Waurn Ponds, VIC, Aus...
Guardado en:
Autores principales: | Roy K, Kanwar RK, Kanwar JR |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6e07a0b27e6b4cbda9649b00a41b4440 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model
por: Roy K, et al.
Publicado: (2015) -
Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
por: Kanwar JR, et al.
Publicado: (2012) -
Oral administration of iron-saturated bovine lactoferrin–loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism
por: Mahidhara G, et al.
Publicado: (2015) -
Nanoformulated cell-penetrating survivin mutant and its dual actions
por: Sriramoju B, et al.
Publicado: (2014) -
Oral administration of encapsulated bovine lactoferrin protein nanocapsules against intracellular parasite Toxoplasma gondii
por: An, et al.
Publicado: (2015)